Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Engel

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
European Journal of Medicinal Chemistry|November 20, 2024
Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffoldHend Khalifa, Ahmed K ElHady, Ting Liu, et al.
Arthritis and Rheumatism|July 10, 2010
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosisSieglinde Marquart, Pawel Zerr, Alfiya Akhmetshina, et al.
Archiv Der Pharmazie|February 2, 2024
Development and evaluation of 2,4-disubstituted-5-aryl pyrimidine derivatives as antibacterial agentsHend Khalifa, Sari Rasheed, Jörg Haupenthal, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2022
Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid partSarah H Megahed, Sari Rasheed, Jennifer Herrmann, et al.
Chemical & Pharmaceutical Bulletin|January 5, 2016
Synthesis and Optimization of New 3,6-Disubstitutedindole Derivatives and Their Evaluation as Anticancer Agents Targeting the MDM2/MDMx ComplexMohamed Salah Rezk, Mohammad Abdel-Halim, Adam Keeton, et al.
Bioorganic & Medicinal Chemistry|October 22, 2013
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53Mohammad Abdel-Halim, Adam B Keeton, Evrim Gurpinar, et al.
Journal of Medicinal Chemistry|January 29, 2019
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding SiteBenoît Bestgen, Isabelle Krimm, Irina Kufareva, et al.
European Journal of Medicinal Chemistry|May 6, 2026
Benzothiophene nucleus in target-directed anti-cancer drug discoveryPatrick M Maximous, Michael Emad, Parthiena M Keddis, et al.
Bioorganic Chemistry|March 22, 2020
Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitorsAhmed K ElHady, Shou-Ping Shih, Yu-Cheng Chen, et al.
Bioorganic Chemistry|October 26, 2021
Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Optimization of the 2,4-substituentsDina Aboushady, Sari S Rasheed, Jennifer Herrmann, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
European Journal of Medicinal Chemistry|November 20, 2024
Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffoldHend Khalifa, Ahmed K ElHady, Ting Liu, et al.
Arthritis and Rheumatism|July 10, 2010
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosisSieglinde Marquart, Pawel Zerr, Alfiya Akhmetshina, et al.
Archiv Der Pharmazie|February 2, 2024
Development and evaluation of 2,4-disubstituted-5-aryl pyrimidine derivatives as antibacterial agentsHend Khalifa, Sari Rasheed, Jörg Haupenthal, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2022
Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid partSarah H Megahed, Sari Rasheed, Jennifer Herrmann, et al.
Chemical & Pharmaceutical Bulletin|January 5, 2016
Synthesis and Optimization of New 3,6-Disubstitutedindole Derivatives and Their Evaluation as Anticancer Agents Targeting the MDM2/MDMx ComplexMohamed Salah Rezk, Mohammad Abdel-Halim, Adam Keeton, et al.
Bioorganic & Medicinal Chemistry|October 22, 2013
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53Mohammad Abdel-Halim, Adam B Keeton, Evrim Gurpinar, et al.
Journal of Medicinal Chemistry|January 29, 2019
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding SiteBenoît Bestgen, Isabelle Krimm, Irina Kufareva, et al.
European Journal of Medicinal Chemistry|May 6, 2026
Benzothiophene nucleus in target-directed anti-cancer drug discoveryPatrick M Maximous, Michael Emad, Parthiena M Keddis, et al.
Bioorganic Chemistry|March 22, 2020
Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitorsAhmed K ElHady, Shou-Ping Shih, Yu-Cheng Chen, et al.
Bioorganic Chemistry|October 26, 2021
Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Optimization of the 2,4-substituentsDina Aboushady, Sari S Rasheed, Jennifer Herrmann, et al.
Pageof 8